Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.
about
CD8 T Cell-Independent Antitumor Response and Its Potential for Treatment of Malignant GliomasNeutrophils in Cancer: Two Sides of the Same CoinNatural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor ActivityThe Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor BedsRegulatory myeloid cells in transplantationReciprocal relationship between myeloid-derived suppressor cells and T cellsMyeloid-derived suppressor cells as therapeutic target in hematological malignanciesDeregulation of innate immune and inflammatory signaling in myelodysplastic syndromesThe Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer ProgressionSignal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapyAnti-tumor immunity: myeloid leukocytes control the immune landscapeCoordinated regulation of myeloid cells by tumoursSuppression of proteoglycan-induced autoimmune arthritis by myeloid-derived suppressor cells generated in vitro from murine bone marrowMesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia PatientsMyeloid-derived suppressor cells: the dark knight or the joker in viral infections?Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species.Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway.Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines.Myelodysplastic syndromes: the role of the immune system in pathogenesis.CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.Vaccine-induced myeloid cell population dampens protective immunity to SIVEvaluation of the therapeutic potential of bone marrow-derived myeloid suppressor cell (MDSC) adoptive transfer in mouse models of autoimmunity and allograft rejection.Advances in graft-versus-host disease biology and therapy.Bioactive compounds or metabolites from black raspberries modulate T lymphocyte proliferation, myeloid cell differentiation and Jak/STAT signaling.Identification of myeloid-derived suppressor cells in the synovial fluid of patients with rheumatoid arthritis: a pilot study.IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.Immunotherapy for lung cancers.Chronic intake of high fish oil diet induces myeloid-derived suppressor cells to promote tumor growth.Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients.Molecular pathways: myeloid complicity in cancer.Resistance to Streptozotocin-Induced Autoimmune Diabetes in Absence of Complement C3: Myeloid-Derived Suppressor Cells Play a Role.Myeloid-derived suppressor cells modulate immune responses independently of NADPH oxidase in the ovarian tumor microenvironment in mice.Dual specificity phosphatase 1 regulates human inducible nitric oxide synthase expression by p38 MAP kinaseLPS-induced CD11b+Gr1(int)F4/80+ regulatory myeloid cells suppress allergen-induced airway inflammation.Anti-HMGB1 monoclonal antibody ameliorates immunosuppression after peripheral tissue trauma: attenuated T-lymphocyte response and increased splenic CD11b (+) Gr-1 (+) myeloid-derived suppressor cells require HMGB1.Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell linesUSC-HN2, a new model cell line for recurrent oral cavity squamous cell carcinoma with immunosuppressive characteristics.Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.Dopamine inhibits the function of Gr-1+CD115+ myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity.Pathogenic fungi regulate immunity by inducing neutrophilic myeloid-derived suppressor cells.
P2860
Q26740520-97C3BEB9-6308-4960-840E-6A12B0603E6FQ26773072-89B02D8E-EFF7-45C5-94A7-CD3AD85C3666Q26773135-73EF61DA-B911-465C-BB9C-E2D1D9F0310CQ26799120-C0889A15-A379-4A17-86CC-05A94B8C41ABQ26999875-BDC1EC97-BF8A-4CAD-A08D-FFC4786F7BBCQ27000664-0F1265D2-1D88-46D0-B011-1C5BE1C8795AQ27010234-2E00543D-9958-489B-96EC-23999BC41F36Q27015288-D8D46636-47A6-4A97-93FC-D792E3E25E65Q28076760-1807594A-ED8C-467B-8DE8-58F216E37236Q28080262-26FDA93F-8CD1-47C9-BD91-1464C510C016Q28390573-13AA0C67-C57B-4F9C-973C-DFB914AE21A9Q28395157-F48F69FF-24EF-462C-A4BA-F74E211354B2Q28544715-A26CB5B4-9F0E-41EF-B311-2A2EED8D1165Q28552532-8C0EDE0F-B818-4B6D-BE7B-B340C0ED1697Q30411008-E06C9B6F-9CEA-4809-BB32-CE4BF239C4E6Q30422587-02C90520-409E-4CF7-9071-CF221A14CBC4Q30427748-32D241FF-3E35-402C-BBED-4E7FB298CE6FQ31085777-93E6515C-0AA5-43FB-B366-97E2DE0282B4Q33351527-9846D195-DAA1-498F-A6AF-9AF1C9D0199CQ33585293-BFDD1980-4150-4448-834E-428B8428DAECQ33685961-B542A015-2996-422E-A0EE-F4367A7E973CQ33754157-9E481B0C-7022-4532-BA34-F93B94DD6CDCQ34031916-31494668-947C-43F0-BE68-CAD7C530EBD9Q34079557-408FBD62-F9B8-4BB1-9B60-AE9B4430A0C7Q34123559-D6150D87-5D97-4EA4-B09A-80CFEAB389B8Q34483744-915FB24F-667C-426C-B6B7-FA040CB8FA55Q34557611-C570D740-3F56-44C9-B8A9-A7E3B3F1A079Q34579989-C617201D-4CF3-4D52-A574-8198D08CE8BAQ34667638-38B3CDD6-521C-4F6E-99D8-225B8375E305Q34725969-71F08BA3-0BBC-429C-AC74-C55A59D0E294Q34793522-9008AA46-0155-4681-B5D3-E1714367BE30Q34903354-DB1AE1BD-46E2-41A8-A415-51A9A0323CC4Q34907847-75180631-7215-4359-B050-D56F8DB92325Q35028319-07670AFE-5F19-4D0C-8B83-236B4B04D4E7Q35076030-FF3CE58C-1E36-4F4A-9475-E51A349C0D24Q35082018-35BDF113-9434-4840-B7FF-A01FCBC755EEQ35189469-9F04ACE3-56E7-44FF-BF7B-CB8FF8920D20Q35222367-87414259-252E-475C-8192-60644FAE315CQ35227738-70E86979-86B8-4B22-8081-A70620A8BBFCQ35450411-ABC9D352-FF97-4B02-95E2-78C8354BF509
P2860
Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Characterization of cytokine-i ...... heral blood mononuclear cells.
@ast
Characterization of cytokine-i ...... heral blood mononuclear cells.
@en
Characterization of cytokine-i ...... heral blood mononuclear cells.
@nl
type
label
Characterization of cytokine-i ...... heral blood mononuclear cells.
@ast
Characterization of cytokine-i ...... heral blood mononuclear cells.
@en
Characterization of cytokine-i ...... heral blood mononuclear cells.
@nl
prefLabel
Characterization of cytokine-i ...... heral blood mononuclear cells.
@ast
Characterization of cytokine-i ...... heral blood mononuclear cells.
@en
Characterization of cytokine-i ...... heral blood mononuclear cells.
@nl
P2093
P2860
P356
P1476
Characterization of cytokine-i ...... heral blood mononuclear cells.
@en
P2093
Alan L Epstein
Daniel J Liebertz
Melissa G Lechner
P2860
P304
P356
10.4049/JIMMUNOL.1000901
P407
P577
2010-07-19T00:00:00Z